Rocaglates Induce Gain-of-Function Alterations to eIF4A and eIF4F-Reference-Cited by-同舟云学术

Rocaglates Induce Gain-of-Function Alterations to eIF4A and eIF4F

Published:2020-02 Issue:8 Volume:30 Page:2481-2488.e5
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Chu Jennifer,Zhang Wenhan,Cencic Regina,O’Connor Patrick B.F.,Robert Francis,Devine William G.,Selznick Asher,Henkel Thomas,Merrick William C.,Brown Lauren E.,Baranov Pavel V.,Porco John A.,Pelletier Jerry

Funder

Canadian HIV Trials Network, Canadian Institutes of Health Research

National Institutes of Health

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference20 articles.

1. Oxygen and glucose deprivation induces widespread alterations in mRNA translation within 20 minutes;Andreev;Genome Biol.,2015

2. CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4A;Chu;Cell Rep.,2016

3. Amidino-Rocaglates: A Potent Class of eIF4A Inhibitors;Chu;Cell Chem. Biol.,2019

4. Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity;Feoktistova;Proc. Natl. Acad. Sci. USA,2013

5. Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor;Iwasaki;Nature,2016

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amidino-rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis;Antiviral Research;2024-10

2. DMDA-PatA mediates RNA sequence-selective translation repression by anchoring eIF4A and DDX3 to GNG motifs;Nature Communications;2024-09-02

3. Calibrated ribosome profiling assesses the dynamics of ribosomal flux on transcripts;Nature Communications;2024-08-26

4. Anti-tumor effects of the eIF4A inhibitor didesmethylrocaglamide and its derivatives in human and canine osteosarcomas;Scientific Reports;2024-08-20

5. Identification of Rocaglate Acyl Sulfamides as Selective Inhibitors of Glioblastoma Stem Cells;ACS Central Science;2024-08-08